In accordance with ACR guidelines, allopurinol is strongly advisable as a primary-line urate-reducing medication. Genetic tests is suggested (for your variant referred to as HLA B*5801) just before beginning allopurinol since the carriers of the gene are at an increased hazard of the intense allergic reaction.Dengan mencegah serangan ini, anda dapa